- Home
- CLLS vs MQT Comparison
CLLS vs MQT Comparison
Compare CLLS & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- MQT
- Stock Information
- Founded
- CLLS 1999
- MQT 1992
- Country
- CLLS France
- MQT United States
- Employees
- CLLS N/A
- MQT N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- MQT Investment Bankers/Brokers/Service
- Sector
- CLLS Health Care
- MQT Finance
- Exchange
- CLLS Nasdaq
- MQT Nasdaq
- Market Cap
- CLLS 143.4M
- MQT 210.8M
- IPO Year
- CLLS 2007
- MQT N/A
- Fundamental
- Price
- CLLS $1.58
- MQT $9.67
- Analyst Decision
- CLLS Buy
- MQT
- Analyst Count
- CLLS 1
- MQT 0
- Target Price
- CLLS $4.00
- MQT N/A
- AVG Volume (30 Days)
- CLLS 54.7K
- MQT 52.5K
- Earning Date
- CLLS 08-05-2025
- MQT 01-01-0001
- Dividend Yield
- CLLS N/A
- MQT 4.60%
- EPS Growth
- CLLS N/A
- MQT N/A
- EPS
- CLLS N/A
- MQT N/A
- Revenue
- CLLS $54,747,000.00
- MQT N/A
- Revenue This Year
- CLLS $48.52
- MQT N/A
- Revenue Next Year
- CLLS $5.17
- MQT N/A
- P/E Ratio
- CLLS N/A
- MQT N/A
- Revenue Growth
- CLLS 351.26
- MQT N/A
- 52 Week Low
- CLLS $1.10
- MQT $8.59
- 52 Week High
- CLLS $2.43
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- CLLS 64.58
- MQT 59.65
- Support Level
- CLLS $1.41
- MQT $9.51
- Resistance Level
- CLLS $1.65
- MQT $9.58
- Average True Range (ATR)
- CLLS 0.10
- MQT 0.06
- MACD
- CLLS 0.03
- MQT 0.03
- Stochastic Oscillator
- CLLS 93.81
- MQT 88.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.